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Dengue and
Relative
Bradycardia 
To the Editor: We have found
that relative bradycardia is a notable
clinical feature of dengue fever in
Singapore. To our knowledge, this
sign has not been previously associat-
ed with dengue. Awareness of this
possible clinical finding could help in
the early recognition of dengue and
potentially reduce complications and
death associated with dengue virus
infection. Clinical features that can be
used in the initial assessment of
febrile patients are essential tools for
clinicians, especially in limited
resource settings.
Dengue fever is a potentially fatal
illness; >2.5 billion persons are at risk
and the disease is endemic in almost
100 countries (1). Singapore recorded
>14,000 cases in 2005, its highest
annual figure (2). No specific clinical
features distinguish dengue from
other febrile illnesses (3); thus, diag-
nosis relies heavily on results of labo-
ratory investigations. Virus-specific
immunoglobulin M (IgM) antibodies
only become detectable after 5–7
days, and false-positive results can
confound the diagnosis. PCR is a use-
ful diagnostic tool; however, it is lim-
ited by the short duration of viremia
and requirements for sophisticated
laboratory support (4).
Relative bradycardia has been
reported in many infectious diseases,
including typhoid fever, Legionnaires’
disease, psittacosis, typhus, leptospir-
osis, malaria, and babesiosis (5,6).
During the 2005 Singapore outbreak,
we observed relative bradycardia in
several patients with dengue fever. We
therefore performed a case-control
study comparing febrile dengue
patients to patients with other infec-
tious diseases. The study was approved
by our hospital’s ethics committee.
The records of all patients admit-
ted with a febrile illness to our gener-
al medical unit from June 1 to October
31, 2005, were reviewed. Patients
with a clinical diagnosis of dengue
fever and serologic confirmation
(IgM or PCR positive) plus a temper-
ature >38°C were included as case-
patients. Age-matched controls were
selected from the same general med-
ical inpatient units and were admitted
during the same period. All had fever,
but they had a proven alternative diag-
nosis, including pneumonia (12
patients), upper respiratory tract
infection (9 patients), urinary tract
infection (6 patients), tuberculosis,
liver abscess, viral fever other than
dengue (3 patients each), meningitis,
chickenpox, cellulitis, typhoid fever
(2 patients each), and appendicitis,
psoas abscess, typhus, infective endo-
carditis, pressure ulcers, and gastroen-
teritis (1 patient each). Exclusion cri-
teria were the following: no laborato-
ry confirmation, age <18 years or >60
years, preexisting substantial heart or
lung disease or concurrent medication
affecting heart rate, e.g., β-blockers,
β-agonists, calcium channel blockers,
or xanthine derivatives.
The peak temperature of all case-
patients and controls was recorded
within the first 24 hours of admission
as well as heart rate and blood pres-
sure at that point. Leukocyte count,
hemoglobin concentration, hemat-
ocrit, and platelet counts were also
noted. Data from 50 case-patients and
50 controls were tabulated and ana-
lyzed with Microsoft Excel
(Microsoft Corp., Redmond, WA,
USA).
The mean age (± standard devia-
tion) for dengue patients was 32.8
(±10.8) years and for controls was
36.5 (±10.2) years (p = 0.08). There
were 39 male patients in the dengue
group and 31 in the control group.
Their mean peak temperatures were
comparable: 38.6°C (±0.5) (dengue)
and 38.8°C (±0.7) (controls) (p =
0.09). Mean heart rates were signifi-
cantly lower in the dengue group:
87.6 (±12.5) beats/min (dengue) and
104.6 (±14) beats/min (controls)
(p<0.0001).
Electrocardiographs (ECGs)
were available for 10 of the dengue
group, and all showed normal sinus
rhythm. Three patients with bradycar-
dia had an ECG. Results for 2 patients
were normal; 1 showed mitral valve
prolapse with mild regurgitation. Ten
patients in the control group under-
went an ECG, and none had any
notable abnormality. Four controls
had ECGs, results for 2 were normal;
1 had mild mitral regurgitation, and 1
had mild tricuspid regurgitation. The
heart rates at peak temperatures for
patients with dengue fever were com-
pared with rates for controls at all
temperatures. Our findings demon-
strate a consistently lower heart rate at
all peak temperatures recorded
(p<0.0001) (Figure).
Dengue fever may adversely
affect cardiac function. An echocar-
diographic study by Khongphattha-
nayothin et al. (7) showed depressed
myocardial contractility and subopti-
mal heart rate response in some
patients with dengue hemorrhagic
fever. Acute reversible hypokinesia
and reduction in left ventricular ejec-
tion fraction was also reported by Wali
et al. (8). The underlying mechanisms
were postulated to be immune in ori-
gin, although myocarditis may be a
contributory factor. Fever production
in response to exogenous pyrogens is
believed to be mediated mostly by
cytokine prostaglandin pathways, and
neural input is important in the early
phases of fever (9). Concentrations of
cytokines, including tumor necrosis
factor, interferon-γ, interleukin-8 (IL-
8), IL-10, and IL-12, are substantially
increased during dengue infection.
Their levels likely correlate with spe-
cific clinical manifestations and illness
severity (10). The relationship of
cytokines to relative bradycardia is
unknown. Further studies could con-
sider the relative importance of
immune and neural mechanisms and
also any direct cardiac pathology in
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the etiology of dengue-associated
relative bradycardia.
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West Nile Virus,
Venezuela 
To the Editor: West Nile virus
(WNV; genus Flavivirus; family
Flaviviridae) has been perpetuating in
North America since 1999 (1).
However, its status as a self-perpetu-
ating pathogen in South America
remains uncertain. Infected horses
and birds have been reported in vari-
ous Caribbean Islands, Mexico, and
northern Central America (2,3). In
South America, isolated reports of
infected dead-end hosts (horses) have
come from northern Colombia and
Argentina, but they lack evidence for
infection in avian amplifying hosts
(4,5). We report serologic evidence of
establishment of WNV in South
America.
Serum samples from birds and
horses from 33 locations in
Venezuela (Online Appendix Table,
available from http://www.cdc.gov/
EID/content/13/4/651-appT.htm)
were screened for immunoglobulin G
(IgG) antibodies against WNV anti-
gen by ELISA (6) and confirmed by
plaque  reduction neutralization test
(PRNT) as previously described (7).
The flavivirus generating the IgG
response was identified by using the
following criteria: 90% inhibition of
virus in serum diluted at least 1:40
and 4-fold greater neutralizing anti-
body titer compared with closely
related flaviviruses. IgG antibody
against flavivirus was detected by
ELISA in 14 of 576 resident birds,
including 5 Turdus leucomelas, 3
Gallus gallus (captive), 2 Campylor-
hamphus trochilirostris, and 1 each of
Elaenia flavogaster, Coereba flaveo-
la, Thraupis palmarum, and Anisog-
nathus flavinucha. 
WNV was confirmed as the etio-
logic agent of infection in 5 adult
birds (3 T. leucomelas [pale-breasted
thrush], 1 C.  flaveola [bananaquit],
and 1 G.  gallus [domestic chicken]
with the earliest collection date in
February 2006); virus neutralization
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Figure. Temperature and heart rate relationship: scatter plot for patients with dengue fever
and nondengue febrile illnesses.